SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT" or the “Company”) (Cboe CA:TILT) (OTCID: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced today the closing of the sale of two of its Massachusetts dispensaries to In Good Health. The definitive agreement for this transaction was previously announced on February 3, 2025. Simultaneously, with the closing, ...

GARDNER, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it will participate in a webcast presentation at the Lytham Partners 2025 Consumer & Technology Investor Summit, taking place virtually on Tuesday, August 19, 2025. The webcast will take place at 9:30 a.m. ET on Tuesday, August 19, 2025. The webcast can be ...

Record Fourth Quarter Revenue Exceeds Guidance RangeRecord Fiscal Year 2025 Revenue Increases 19% Year-over-year BANGKOK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced its financial results for its fourth quarter and fiscal year ended June 27, 2025. Seamus Grady, Chief Executive Officer of Fabrinet, ...

RICHMOND, Va., Aug. 18, 2025 /PRNewswire/ -- Markel Insurance, the insurance operations within Markel Group Inc. (NYSE: MKL), has completed the sale of the renewal rights for its Global Reinsurance business to Nationwide. This transaction was previously announced on July 30, 2025, and is part of Markel's broader strategy to simplify operations and focus on the distinct needs of its core specialty insurance markets.Nationwide will delegate the underwriting and management of all renewal policies included in t ...

First T cell therapy for a solid tumor cancer and first treatment option approved in Canada for advanced melanoma after anti-PD-1 and targeted therapy SAN CARLOS, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced Health Canada has issued a Notice of Compliance with Conditions (NOC/c) ...

BRENTWOOD, Tenn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- CoreCivic, Inc. (NYSE: CXW) ("CoreCivic" or "Company") announced today that CoreCivic's Board of Directors (the "Board") has appointed Patrick D. Swindle to President and Chief Executive Officer, effective January 1, 2026. This follows Mr. Swindle’s appointment as President and Chief Operating Officer on January 1, 2025. Mr. Swindle will succeed Damon T. Hininger, who has served as Chief Executive Officer since August 17, 2009. In addition, effective Janua ...

SURPRISE, Ariz., Aug. 18, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control for managing animal pest populations, today announced that it will participate in a webcast presentation at the Lytham Partners 2025 Consumer & Technology Investor Summit, taking place virtually on Tuesday, August 19, 2025.The webcast will take place at 3:30 p.m. ET on Tuesday, August 19, 2025. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/cts2025/ or ...

Toronto, Ontario--(Newsfile Corp. - Le 18 août/August 2025) - Treatment.com AI Inc. (TRUE) has announced a name and symbol change to Rocket Doctor AI Inc. (AIDR). Shares will begin trading under the new name and symbol and with a new CUSIP number on August 21 , 2025. Disclosure documents are available at www.thecse.com. Please note that all open orders will be canceled at the end of business on August 20, 2025. Dealers are reminded to re-enter their orders. _________________________________ Treat ...

If you thought our angle on this company was interesting, you may want to check out our idea room, The Value Lab . We focus on long-only value ideas of interest to us, where we try to find international mispriced equities and target a portfolio yield of about 4% . We've done really well for ourselves over the last 5 years, but it took getting our hands dirty in international markets. If you are a value-investor, serious about protecting your wealth, our gang could help broaden your horizons and give some in ...

REGULATED INFORMATION Nyxoah Reports Second Quarter Financial and Operating ResultsFDA Approves Genio® System for U.S. Market; Company Begins Commercial Launch Mont-Saint-Guibert, Belgium – August 18, 2025, 10:10pm CET / 4:10 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today reported financial and operating results for the second quarte ...